“Very few companies would make the bet that we’re making,” Kevin Sayer.
In the first half of our interview with De…
Products & Tech
The Dexcom Interview, Part 1: “Standard of Care”
ASweetLife was lucky enough to score an interview with Kevin Sayer, the President & CEO of Dexcom.
We are publishing…
FDA Issues Warning Regarding Cybersecurity Risks for Certain Medtronic Insulin Pumps
On June 27, 2019, the FDA issued a warning patients and health care providers that certain Medtronic MiniMed™ insulin pu…
FDA Approves Victoza for Children with Type 2 Diabetes
On June 17, the FDA announced that it had approved a new drug for the treatment of pediatric Type 2 diabetes:
“The U.S. …
iLet Bihormonal Bionic Pancreas Clinical Trial Begins
Are two hormones better than one? A new clinical trial aims to find out.
Massachusetts startup Beta Bionics and Danish b…
Medtronic Plans to Develop a Bluetooth-Enabled MiniMed Pump Compatible with Tidepool Loop
Medtronic and Tidepool, a nonprofit organization dedicated to making diabetes data more accessible, actionable and meani…
Medtronic Releases Data From Users of the Closed Loop Minimed 670G System
This week Medtronic released data from its 180,000 users of the Minimed 670G, touting impressive outcomes with the autom…
EOPancreas: A Closed Loop Insulin Patch Pump in Development
Earlier this month, EOFlow, an emerging medical device company with offices in Seoul, South Korea and San Jose, Californ…
FDA Rejects Sanofi-Lexicon Oral Medication for Type 1 Diabetes
The FDA has denied approval of Sanofi and Lexicon’s drug, sotagliflozin, as an add-on to insulin therapy in the tr…
Tandem’s Control-IQ Explained
Last fall, I wrote about how glad my husband and I were that our daughter, Bisi, had pushed to switch to the t:slim X2 …